Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Laryngeal Diseases 1Hyperphagia 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 11Cetuximab 10Radiotherapy 7Fluorouracil 6Docetaxel 5pembrolizumab 4Carboplatin 4figitumumab 3Radiation 3Paclitaxel 3Erlotinib Hydrochloride 3Bleomycin 3130-nm albumin-bound paclitaxel 3talimogene laherparepvec 2avelumab 2Surgical Procedures, Operative 2Oxaliplatin 2Lapatinib 2Capecitabine 2zalutumumab 1yeast-CEA vaccine 1temsirolimus 1temoporfin 1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1selinexor 1remetinostat 1ponatinib 1patritumab 1nilotinib 1necitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Squamous Cell × Emulsions × Clear all
NCT02236936 2020-05-01

AGMT_HNO_PN

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 3 Terminated
8 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Hyperphagia, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡